Levofloxacin vs Rituximab
Levofloxacin vs Rituximab: Overview
This comparison examines the pharmacological differences between Levofloxacin and Rituximab.
Mechanism of Action
Levofloxacin: Fluoroquinolone antibiotic inhibiting bacterial DNA gyrase and topoisomerase IV.
Rituximab: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.
Pharmacokinetics
Half-life: Levofloxacin β 6-8 hours; Rituximab β 22 days.
Chemical Properties
Molecular Formula: Levofloxacin β C18H20FN3O4.
Molecular Weight: Levofloxacin β 361.3680 g/mol.
Type: Levofloxacin β Small molecule; Rituximab β Antibody.